2,6-Diaza-spiro[3.4]octane-6-carboxylic acidtert-butyl ester
95%
- Product Code: 75106
CAS:
885270-86-0
| Molecular Weight: | 212.29 g./mol | Molecular Formula: | C₁₁H₂₀N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08234738 | |
| Melting Point: | Boiling Point: | 301.3℃ at 760 mmHg | |
| Density: | 1.1g/ml | Storage Condition: | 2-8°C, protected from light, inert gas |
Product Description:
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its spirocyclic structure is particularly valuable in drug discovery, especially for developing compounds targeting central nervous system disorders. The tert-butyl ester group enhances the molecule's stability, making it suitable for use in multi-step synthetic processes. Researchers often employ it in the preparation of potential therapeutic agents, including those with anti-inflammatory, antimicrobial, or neuroprotective properties. Its unique structure also allows for the exploration of novel chemical spaces, aiding in the development of innovative drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | €127.98 |
+
-
|
| 1.000 | 10-20 days | €416.70 |
+
-
|
2,6-Diaza-spiro[3.4]octane-6-carboxylic acidtert-butyl ester
Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various biologically active molecules. Its spirocyclic structure is particularly valuable in drug discovery, especially for developing compounds targeting central nervous system disorders. The tert-butyl ester group enhances the molecule's stability, making it suitable for use in multi-step synthetic processes. Researchers often employ it in the preparation of potential therapeutic agents, including those with anti-inflammatory, antimicrobial, or neuroprotective properties. Its unique structure also allows for the exploration of novel chemical spaces, aiding in the development of innovative drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :